Medicus Pharma (MDCX) Other Operating Expenses (2024 - 2025)
Medicus Pharma's (MDCX) quarterly Other Operating Expenses came in at $3.6 million in Q4 2025, up 162.76% YoY from $1.4 million in Q4 2024, and up 141.15% on a QoQ basis from -$8.7 million in Q3 2025.
Medicus Pharma (MDCX) Other Operating Expenses (2024 - 2025) Analysis & Trends
Medicus Pharma (MDCX) has 2 years of Other Operating Expenses data on file, last reported at $3.6 million in Q4 2025.
- Quarterly Other Operating Expenses rose 162.76% year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.1 million (down 365.93% YoY) and the FY2025 annual result came in at $8.7 million, up 147.11% from the prior year.
- Other Operating Expenses advanced to $3.6 million in Q4 2025, from -$8.7 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $3.6 million in Q4 2025 to a low of -$8.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.59 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 564,145.00 |